A study from the Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA has reported that “miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.”
This study was published in the June 25, 2014 Nature [I.F >42] by Prof. Wan Y, Krzeszinski and others from the Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that: Natural product therapy for Bone disorders: Caffeine, one of the principal components of Coffee, inhibits osteoporosis and bone metastasis via up-regulation of its target gene.
Idea Proposed/Formulated by: Dr L Boominathan PhD
Significance:
Coffee, by up-regulating its target gene, it may suppress the expression of Tgif2. Together, this study suggests that pharmacological formulations encompassing “Coffee or its pharmacologically safer non-toxic analogs” can be used to inhibit osteoporosis and bone metastasis.
Coffeine, the major component of Coffee.
Citation: Boominathan, Natural product therapy for Bone disorders: Caffeine, one of the principal components of Coffee, inhibits osteoporosis and bone metastasis via up-regulation of its target gene. 13/October/2016, 5.55 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
Web: http://genomediscovery.org or http://newbioideas.com
Undisclosed information: How Caffeine suppresses the expression of Tgif2
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
#Research cooperation
Amount: $100
Results guaranteed if not refunded